Virology Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Virology Market
Virology Market: By type (diagnosing test, viral infection controlling methods, antiviral chemotheraphy, interferon ); By application (skin & soft tissue infections, respiratory tract infections, others); By end-use (hospitals, clinics, laboratories, others); By Geography - Forecast(2018-2023)
Report Code : HCR 0423
Updated Date: 24 July, 2018  

1. Virology Market Overview
2. Executive Summary
3. Virology Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis 
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Virology Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Virology Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Virology Market - By type
   6.1. Introduction
   6.2. Diagnosing Test
      6.2.1. DNA viruses
      6.2.2. RNA viruses
      6.2.3. Prions diagnostic test
      6.2.4. Others
   6.3. Viral Infection Controlling Methods
      6.3.1. Passive Prophylaxis
      6.3.2. Immunoprophylaxis
      6.3.3. Active Prophylaxis (Vaccines)
   6.4. Antiviral Chemotherapy
      6.4.1. Antiviral Agents
      6.4.2. Immunomodulators
      6.4.3. Virucidal Agents
   6.5. Interferon
      6.5.1. Cytokines
7. Virology Market - By application
   7.1. Skin and Soft Tissue Infections
   7.2. Respiratory Tract Infections
   7.3. GI Tract Infections
   7.4. Urinary Tract Infections
   7.5. Eye Infections
   7.6. CNS Infections
   7.7. Sexually Transmitted Diseases
   7.8. Perinatal Infections
8. Virology Market – By End-users
   8.1. Hospitals
   8.2. Clinics
   8.3. Laboratories
   8.4. Diagnostic Centers
   8.5. Blood Banks   
   8.6. Pharmacies
9. Virology Substrate Market - By Geography
   9.1. North America 
      9.1.1. U.S.  
      9.1.2. Canada 
      9.1.3. Mexico 
      9.1.4. Rest of North America
   9.2. South America 
      9.2.1. Brazil 
      9.2.2. Venezuela
      9.2.3. Argentina
      9.2.4. Ecuador
      9.2.5. Peru
      9.2.6. Colombia 
      9.2.7. Costa Rica
      9.2.8. Rest of South America
   9.3. Europe 
      9.3.1. U.K 
      9.3.2. Germany 
      9.3.3. Italy 
      9.3.4. France
      9.3.5. Netherlands
      9.3.6. Belgium
      9.3.7. Spain
      9.3.8. Denmark
      9.3.9. Rest of Europe
   9.4. APAC
      9.4.1. China 
      9.4.2. Australia 
      9.4.3. South Korea
      9.4.4. India
      9.4.5. Taiwan
      9.4.6. Malaysia
      9.4.7. Hong Kong  
      9.4.8. Rest of APAC
   9.5. Middle East& Africa 
      9.5.1. Israel
      9.5.2. South Africa
      9.5.3. Saudi Arabia
   9.6. Rest of Middle East and Africa
10. Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs, Partnership
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. GlaxoSmithKline plc
   11.2. Abbott Laboratories
   11.3. Boehringer Ingelheim Corporation
   11.4. Merck and Co. Inc.
   11.5. Novartis International AG
   11.6. Company 6
   11.7. Company 7
   11.8. Company 8
   11.9. Company 9
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll